相关实验视频

Updated: May 6, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

抗血管内皮生长因子与甲植入物治疗结合用于斑点的治疗:一项随机对照试验

Yunxi Ma¹, Junwen Wang¹, Mingzhu Yuan¹

¹Department of Ophthalmology, Hubei Key Laboratory of Otolaryngologic and Ophthalmic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.

Drug design, development and therapy

|March 9, 2026

概括

与单独使用conbercept相比,将conbercept与甲植入物 (DEX) 结合起来,可以为斑点 (ME) 提供更快的视觉和解剖改善. 这种组合治疗需要更少的注射,并显示持续的长期疗效.

科学领域:

眼科医生眼科眼科
视网膜疾病视网膜疾病
药理学药理学是指药理学的学科.

背景情况:

斑点 (ME) 显著损害视力,通常是由于糖尿病视网膜病变或视网膜静脉封闭造成的.
内治疗对于治疗ME至关重要,目前正在进行的研究正在探索最佳治疗策略.

研究的目的:

为了比较intravitreal conbercept单一疗法的疗效和安全性,与用于治疗ME的甲植入物 (DEX) 组合疗法相比.
评估两种治疗方法的视力敏度,解剖学变化和安全性.

主要方法:

一项随机对照试验,涉及70名糖尿病视网膜病变或视网膜静脉封闭后的ME患者.
患者被分配到康伯塞普单独治疗或康伯塞普加DEX联合治疗.
结果包括最佳校正视敏度 (BCVA) 的变化,光学连贯性断层扫描 (OCT) 生物标志物和48周随访期间的不良事件.

主要成果:

组合治疗组在最初的12周内显示出显著更大的BCVA改善和中央黄斑厚度 (CMT) 减少.
在OCT生物标志物中,在初始阶段的组合组中显示出更显著的改善.
组合疗法总体上需要较少的注射,但与较高的眼睛高血压发病率有关.

结论:

与DEX结合的Conbercept为ME患者提供了加速的短期视觉和解剖效益.
长期疗效与conbercept单一疗法相比,注射频率减少的额外优势.
海洋和海域国家/地区的生物标志物具有预后价值,而硬排泄物 (HE) 的存在与视觉结果较差有关.

关键词:

生物标志物生物标志物组合疗法治疗组合治疗.这就是Conbercept的概念.德克萨米他植入物植入物光学连贯性断层扫描 (optical coherence tomography) 是一种光学连贯性断层扫描技术.

更多相关视频

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...